TrialClinical and vaccine immunology : CVI2007

Borreliacidal OspC antibody response of canines with Lyme disease differs significantly from that of humans with Lyme disease.

Steven D Lovrich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.